Scopolamine-induced convulsions in fasted mice after food intake: Determination of blood glucose levels, [3H]glutamate binding kinetics and antidopaminergic drug effects

Neuropharmacology

Volumn 44, Issue 2, 2003, Pages 199-205

  Enginar, N ^a,b   Yamanturk P ^a,b   Nurten, A ^b   Nurten, R ^a,b   Koyuncuoglu H ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Dopamine antagonists; Fasting; Food intake; Hypoglycemia; Scopolamine induced convulsions; 3H glutamate binding

Indexed keywords

CHLORPROMAZINE; DOPAMINE RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; HALOPERIDOL; SCOPOLAMINE; TRITIUM;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; BRAIN; CLONIC SEIZURE; CONTROLLED STUDY; CONVULSION; DENSITY; DIET RESTRICTION; DOPAMINERGIC ACTIVITY; DRUG EFFECT; DRUG INDUCED DISEASE; EVALUATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REFEEDING; SYNAPTIC MEMBRANE;

EID: 0037293999     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00365-9     Document Type: Article

References (38)

1. Alam A.M., Starr M.S. Bimodal effects of dopamine D2 receptor agonists on zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice. Experimental Brain Research. 102:1994;75-83.
2. Anderson D.R., Harris L.W., Bowersox S.L., Lennox W.J., Anders J.C. Efficacy of injectable anticholinergic drugs against soman-induced convulsive/subconvulsive activity. Drug and Chemical Toxicology. 17:1994;139-148.
3. Bauer J.D., Ackerman P.G., Toro G. Clinical Laboratory Methods. 1974;384-385 C.V. Mosby, Saint Louis.
4. Bickler P.E., Hansen B.M. Alpha 2-adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia. Neuropharmacology. 35:1996;679-687.
5. Bo P., Soragna D., Marchioni E., Candeloro E., Albergati A., Savoldi F. Role of dopamine D-1 and D-2 antagonists in a model of focal epilepsy induced by electrical stimulation of hippocampus and amygdala in the rabbit. Progress in Neuropsychopharmacology and Biological Psychiatry. 19:1995;917-930.
6. Burns G.A., Ritter R.C. The non-competitive NMDA antagonist MK-801 increases food intake in rats. Pharmacology Biochemistry and Behavior. 56:1997;145-149.
7. Bymaster F.P., Heath I., Hendrix J.C., Shannon H.E. Comparative behavioural and neurochemical activities of cholinergic antagonists in rats. Journal of Pharmacology and Experimental Therapeutics. 267:1993;16-24.
8. Czuczwar S.J., Frey H.H., Loscher W. Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by antiepileptic drugs and other agents. European Journal of Pharmacology. 108:1985;273-280.
9. Dunn R.W., Corbett R. Yohimbine-induced seizures involve NMDA and GABAergic transmission. Neuropharmacology. 31:1992;389-395.
10. Emmelot P., Bos C.J., van Hoeven P., van Blitterswijk W.J. Isolation of plasma membranes from rat and mouse livers and hepatomas. Methods in Enzymology. 31:1974;75-90.
11. Enginar N., Nurten A., Yamantürk P. Scopolamine-induced convulsions in fasted mice: does this effect contribute to the impairment of performance in some memory tasks? Third European Research Conference on Neural Mechanisms of Learning and Memory. 1996;. Abstract Book 4.2.
12. Enginar N., Nurten A., Yamantürk P., Koyuncuoǧlu H. Scopolamine-induced convulsions in food given fasted mice: effects of physostigmine and MK-801. Epilepsy Research. 28:1997;137-142.
13. Enginar N., Yamantürk P., Nurten A., Koyuncuoǧlu H. Scopolamine-induced convulsions in food given fasted mice: effects of clonidine and tizanidine. Epilepsy Research. 35:1999;155-160.
14. Fisher R.S. Animal models of the epilepsies. Brain Research Reviews. 14:1989;245-278.
15. Ghajar J.B., Gibson G.E., Duffy T.E. Regional acetylcholine metabolism in brain during acute hypoglycemia and recovery. Journal of Neurochemistry. 44:1985;94-98.
16. Kamisaki Y., Hamahashi T., Okada C.M., Itoh T. Clonidine inhibition of potassium-evoked release of glutamate and aspartate from rat cortical synaptosomes. Brain Research. 568:1991;193-198.
17. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
18. Mark G.P., Rada P., Pothos E., Hoebel B.G. Effects of feeding and drinking on acetylcholine release in the nucleus accumbens, striatum, and hippocampus of freely behaving rats. Journal of Neurochemistry. 58:1992;2269-2274.
19. Meeker R.B., McGinnis S., Greenwood R.S., Hayward J.N. Increased hypothalamic glutamate receptors induced by water deprivation. Neuroendocrinology. 60:1994;477-485.
20. Molenaar P.C., Polak R.L. Inhibition of acetylcholine release by activation of acetylcholine receptors. Progressive Pharmacology. 3/4:1980;39-44.
21. Sandberg M., Butcher S.P., Hagberg H. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. Journal of Neurochemistry. 47:1986;178-184.
22. Satoh H., Nakanishi H., Shirakawa K., Kohjimoto Y., Kuwaki T., Ono T., et al. Comparative study of tiapride and neuroleptics with anti-dopamine activity on convulsive seizure in mice. Japanese Journal of Pharmacology. 43:1987;27-32.
23. Schilstrom B., Svensson H.M., Svensson T.H., Nomikos G.G. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of alpha7 nicotinic receptors in the ventral tegmental area. Neuroscience. 85:1998;1005-1009.
24. 1 receptor agonists A-86929 and ABT-431. European Journal of Pharmacology. 317:1996;183-190.
25. Smolders I., van Belle K., Ebinger G., Michotte Y. Hippocampal and cerebellar extracellular amino acids during pilocarpine-induced seizures in freely moving rats. European Journal of Pharmacology. 319:1997;21-29.
26. Stanley B.G., Butterfield B.S., Grewal R.S. NMDA receptor coagonist glycine site: evidence for a lateral hypothalamic stimulation of feeding. The American Journal of Physiology. 273:1997;R790-R796.
27. Starr M.S. The role of dopamine in epilepsy. Synapse. 22:1996;159-194.
28. Steffens A.B., Scheurink A.J.N., Porte D., Woods S.C. Penetration of peripheral glucose and insulin into cerebrospinal fluid in rats. The American Journal of Physiology. 255:1988;R200-R204.
29. Taber M.T., Fibiger H.C. Feeding-evoked dopamine release in the nucleus accumbens: regulation by glutamatergic mechanisms. Neuroscience. 76:1997;1105-1112.
30. Tamasi G.C., Drenick E.J. Resistance to insulin convulsions in fasted mice. Endocrinology. 92:1973;1277-1279.
31. Turski W.A., Cavalheiro E.A., Bortolotto Z.A., Moraes Mello L.E.A., Schwarz M., Turski L. Seizures produced by pilocarpine in mice: a behavioural, electroencephalographic and morphological analysis. Brain Research. 321:1984;237-253.
32. Wade J.V., Samson F.E., Nelson S.R., Pazdernik T.L. Changes in extracellular amino acids during soman- and kainic acid-induced seizures. Journal of Neurochemistry. 49:1987;645-650.
33. Westerink B.H.C., Teisman A., de Vries J.B. Increase in dopamine release from the nucleus accumbens in response to feeding: a model to study interactions between drugs and naturally activated dopaminergic neurons in the rat brain. Naunyn-Schmiedebergs Archieves of Pharmacology. 349:1994;230-235.
34. Westerink B.H.C., Kwint H.F., de Vries J.B. Eating-induced dopamine release from mesolimbic neurons is mediated by NMDA receptors in the ventral tegmental area: a dual-probe microdialysis study. Journal of Neurochemistry. 69:1997;662-668.
35. Wieloch T., Engelsen B., Westerberg E., Auer R. Lesions of the glutamatergic cortico-striatal projections ameliorate hypoglycemic brain damage in the striatum. Neuroscience Letters. 58:1985;25-30.
36. Worms P., Lloyd K.G. Differential blockade of bicuculline convulsions by neuroleptics. European Journal of Pharmacology. 51:1978;85-88.
37. 3H]glutamate in rat adrenal. Biochemical and Biophysical Research Communications. 142:1987;609-616.
38. Yoneda Y., Ogita K. Heterogeneity of the N-methyl-D-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques. Journal of Pharmacology and Experimental Therapeutics. 259:1991;86-96.